1. Background and Problem Statement
Urinary tract infections (UTIs), which affect millions of people each year, remain among the most common infections in community and hospital settings (1). Although many UTIs are uncomplicated and readily treatable (2), inappropriate antibiotic selection and incomplete treatment courses contribute to recurrent infections and the emergence of multidrug-resistant organisms (3). Globally, an estimated 150 million UTI cases occur annually, placing a significant burden on healthcare systems and patients alike (4).
In Iran, national antimicrobial stewardship efforts have primarily focused on hospital settings, whereas patterns of resistance in community-acquired infections remain insufficiently characterized (4, 5). Non-hospital medical laboratories serve as critical access points for patients with mild or moderate infections and therefore provide valuable insight into real-world prescribing needs (6). The absence of routine surveillance data from these settings limits the ability of clinicians and policymakers to develop evidence-based empirical treatment guidelines.
Approximately 13.5% of Iran's population resides in the northwest region of the country, and about 1.6% lives in Qazvin Province, a typical urban setting where community-acquired UTIs are frequently encountered. Understanding local pathogen distribution and susceptibility profiles is essential to prevent treatment failure, reduce healthcare costs, and slow the spread of antimicrobial resistance (7).
2. Materials and Methods
This study was conducted at Mehr Clinical Laboratory in Qazvin Province, Iran. Data were collected from April 2017 to January 2019. A total of 3,521 patients of both sexes and various age groups were included. Clean-catch midstream urine samples were cultured on blood agar and MacConkey agar, and bacterial growth ≥ 10⁴ CFU/mL was considered significant.
Bacterial identification was performed using standard microbiological procedures. Antimicrobial susceptibility testing was carried out by the disk diffusion method on Mueller-Hinton agar in accordance with Clinical and Laboratory Standards Institute (CLSI) guidelines. The antibiotics tested included amikacin, ciprofloxacin, ceftriaxone, gentamicin, nalidixic acid, nitrofurantoin, trimethoprim/sulfamethoxazole, cephalexin, and erythromycin. Statistical analysis was performed using SPSS software.
3. Results and Policy-Relevant Findings
Among the 3,521 patients evaluated, 347 bacterial isolates were recovered, yielding an overall UTI prevalence of 9.9%. Females constituted the majority of affected individuals. A statistically significant association was observed between age and UTI occurrence, with the highest frequency in the 20 - 30-year age group.
Gram-negative bacteria accounted for 81.2% of isolates, whereas gram-positive organisms comprised 18.7%. Escherichia coli was the predominant pathogen (54.5%), followed by Klebsiella pneumoniae. Pseudomonas aeruginosa was the least frequently isolated organism.
Susceptibility testing showed that most gram-negative isolates were highly sensitive to nitrofurantoin, ciprofloxacin, and gentamicin. Conversely, more than half of the isolates demonstrated resistance to nalidixic acid and trimethoprim/sulfamethoxazole. Among gram-positive bacteria, the highest sensitivity was observed for amikacin. These results suggest that a substantial proportion of community-acquired UTIs may no longer respond reliably to traditional first-line antibiotics such as co-trimoxazole and fluoroquinolones, consistent with reports of rising resistance rates worldwide (8).
4. Policy Options and Implementation Strategies
One policy option is the establishment of a routine community-based surveillance system to monitor UTI pathogens and their resistance patterns through selected non-hospital laboratories. Such a system would enable timely updates of empirical treatment recommendations and provide early warning of emerging resistance trends (9).
A second option is the strengthening of antibiotic stewardship in outpatient care. This includes integrating local resistance data into clinical guidelines, promoting culture-based diagnosis for recurrent or complicated UTIs, and providing continuing medical education for general practitioners on rational antibiotic prescribing (10, 11).
A third option involves expanding public education initiatives aimed at reducing self-medication and improving adherence to prescribed antibiotic regimens. Public awareness campaigns can emphasize the dangers of inappropriate antibiotic use and the importance of completing treatment courses (12, 13).
5. Conclusions
Community-acquired UTIs remain common in Iran and are increasingly complicated by antimicrobial resistance. Evidence from non-hospital laboratory surveillance highlights the urgent need for coordinated action at the community level. Implementing targeted surveillance, reinforcing stewardship programs, and improving public awareness can collectively reduce inappropriate antibiotic use and help preserve the effectiveness of existing therapies.
